Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Croitoru

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Infection and Immunity|December 10, 2008
Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitisArmando Heriazon, Pengfei Zhou, Rajka Borojevic, et al.
Gastroenterology|December 18, 2025
Prediction and Prevention of Inflammatory Bowel Disease: A Call to ActionSun-Ho Lee, Emily W Lopes, Hamed Khalili, et al.
Immunology and Cell Biology|June 15, 2007
Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2Linda Wu, Bai-Sui Feng, Shao-Heng He, et al.
Clinical and Translational Gastroenterology|May 23, 2019
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease ActivityWilliams Turpin, Orlaith Kelly, Krzysztof Borowski, et al.
Journal of Crohn'S & Colitis|April 25, 2015
Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptakeGurtej Malhi, Amir Rumman, Reka Thanabalan, et al.
Canadian Journal of Gastroenterology & Hepatology|February 28, 2017
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel DiseaseAmir Rumman, Roberto Candia, Justina J Sam, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
Journal of the Canadian Association of Gastroenterology|April 25, 2020
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing EffectivenessPetros Zezos, Boyko Kabakchiev, Adam V Weizman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2016
The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced EnteropathyGalliano Zanello, Ashleigh Goethel, Sandrine Rouquier, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel DiseaseJoana Torres, Jonas Halfvarson, Iago Rodríguez-Lago, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Infection and Immunity|December 10, 2008
Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitisArmando Heriazon, Pengfei Zhou, Rajka Borojevic, et al.
Gastroenterology|December 18, 2025
Prediction and Prevention of Inflammatory Bowel Disease: A Call to ActionSun-Ho Lee, Emily W Lopes, Hamed Khalili, et al.
Immunology and Cell Biology|June 15, 2007
Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2Linda Wu, Bai-Sui Feng, Shao-Heng He, et al.
Clinical and Translational Gastroenterology|May 23, 2019
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease ActivityWilliams Turpin, Orlaith Kelly, Krzysztof Borowski, et al.
Journal of Crohn'S & Colitis|April 25, 2015
Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptakeGurtej Malhi, Amir Rumman, Reka Thanabalan, et al.
Canadian Journal of Gastroenterology & Hepatology|February 28, 2017
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel DiseaseAmir Rumman, Roberto Candia, Justina J Sam, et al.
Gynecologic Oncology|April 9, 2018
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancerJoyce Liu, Shibani Nicum, Peter Reichardt, et al.
Journal of the Canadian Association of Gastroenterology|April 25, 2020
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing EffectivenessPetros Zezos, Boyko Kabakchiev, Adam V Weizman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2016
The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced EnteropathyGalliano Zanello, Ashleigh Goethel, Sandrine Rouquier, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel DiseaseJoana Torres, Jonas Halfvarson, Iago Rodríguez-Lago, et al.
Pageof 10